4,4′-iminobis-butanoic acid | 6828-42-8

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 4,4′-iminobis-butanoic acid
• 英文别名: 4,4-Bis(N,N-dibutyric acid)；4-(3-carboxypropylamino)butanoic acid
• CAS: 6828-42-8
• 化学式: C₈H₁₅NO₄
• mdl: MFCD01311683
• 分子量: 189.211
• InChiKey: HBUXNNBOWNIKNE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -2.8
• 重原子数：
  13
• 可旋转键数：
  8
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.75
• 拓扑面积：
  86.6
• 氢给体数：
  3
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  4,4′-iminobis-butanoic acid 、 在 三乙胺 作用下， 以 二氯甲烷 为溶剂， 生成 4-[[2-[18-[2-[Bis(3-carboxypropyl)amino]-2-oxoethyl]-11,14,22,26-tetrakis(4-tert-butylphenoxy)-6,8,17,19-tetraoxo-7,18-diazaheptacyclo[14.6.2.22,5.03,12.04,9.013,23.020,24]hexacosa-1(22),2(26),3,5(25),9,11,13,15,20,23-decaen-7-yl]acetyl]-(3-carboxypropyl)amino]butanoic acid
  参考文献：
  名称：

  COMPOUND, PHOTOSENSITIVE FLUORESCENT RESIN COMPOSITION COMPRISING SAME, COLOR CONVERSION FILM MANUFACTURED THEREFROM, BACKLIGHT UNIT, AND DISPLAY DEVICE

  摘要：

  本规范涉及一种化学式1所表示的化合物，包括该化合物的光致发光树脂组合物，以及使用该组合物制造的色彩转换膜，背光单元和显示器设备。

  公开号：

  US20220389014A1

文献信息

• BIO-NANO POWER CELLS AND THEIR USES
  申请人：Long Nathan R.

  公开号：US20130330293A1

  公开（公告）日：2013-12-12

  The present invention concerns bio-nano power cells and methods of their manufacture and use. More particularly, the present invention relates to the preparation of bio-nano power cells that are biocompatible and capable of producing flash, intermittent, or continuous power by electrolyzing compounds in biological systems.

  这项发明涉及生物纳米电池及其制造和使用方法。更具体地，这项发明涉及制备生物纳米电池，这些电池具有生物相容性，并能够通过在生物系统中电解化合物来产生闪光、间歇或持续电力。
• [EN] PEHAM DENDRIMERS FOR USE IN AGRICULTURE<br/>[FR] DENDRIMÈRES POLYÉTHER-HYDROXYLAMINE (PEHAM) DESTINÉS À ÊTRE UTILISÉS EN AGRICULTURE
  申请人：DENDRITIC NANOTECHNOLOGIES INC

  公开号：WO2011053605A1

  公开（公告）日：2011-05-05

  Specific PEHAM dendrimers are used in a formulation with an active agent for agricultural purposes, particularly for increasing the efficacy of the active agent in various ways, such as by improving solubility of the active agent in the formulation, by improving adhesion and penetration of the active agent to plant surfaces, by improving the water- fastness of the active agent to the plant or seed, by providing protection of the active agent from UV damage, by increasing soil penetration of the active agent to reach the plant roots or under soil parts, or by reducing soil adhesion of the active agent to reach the plant roots or under soil parts, or reducing enzymatic degradation of the active agent by the plant or seed or microorganisms in the soil.

  特定的PEHAM树枝状聚合物与活性剂配方一起用于农业目的，特别是通过多种方式增加活性剂的功效，比如改善配方中活性剂的溶解性，改善活性剂对植物表面的粘附和渗透性，改善活性剂对植物或种子的耐水性，提供对活性剂免受紫外线损伤的保护，增加活性剂在土壤中的渗透性以达到植物根部或土壤下部，或通过减少活性剂与土壤的粘附以达到植物根部或土壤下部，或减少植物或种子或土壤中微生物对活性剂的酶降解。
• Novel thyroid receptor ligands and method II
  申请人：Hangeland Jon

  公开号：US20050282872A1

  公开（公告）日：2005-12-22

  New thyroid receptor ligands are provided which have general formula (I) in which: n is an integer from 0 to 4; R 1 is halogen, trifluoromethyl, or alkyl of 1 to 6 carbons or cycloalkyl of 3 to 7 carbons; R 2 and R 3 are the same or differential hydrogen, halogen, alkyl of 1 to 4 carbons or cycloalkyl of 3 to 5 carbons, at least one of R 2 and R 3 being other than hydrogen; R 4 is a carboxylic acid thereof; or when n is equal to or greater than one, R 4 may be heteroaromatic moiety which may be substituted or unsubstituted, or an amine (NR′R″). R 5 is hydrogen or an acyl (such as acetyl or benzoyl) or other group capable of bioconversion to generate the free phenol structure (wherein R 5 —H). In addition, a method is provided for preventing, inhibiting or treating a disease associated with metabolism dysfunction or which is dependant upon the expression of a T 3 regulated gene, wherein a compound as described above is administered in a therapeutically effective amount. Examples of such diseases associated with metabolism dysfunction or are dependent upon the expression of a T 3 regulated gene include obesity, hypercholesterolemia, atherosclerosis, cardiac arrhythmias, depression, osteoporosis, hypothyroidism, goiter, thyroid cancer as well as glaucoma, congestive heart failure and skin disorders.

  提供了新的甲状腺受体配体，其具有以下通式（I）：其中：n是从0到4的整数；R1是卤素、三氟甲基或1至6个碳原子的烷基或3至7个碳原子的环烷基；R2和R3相同或不同，是氢、卤素、1至4个碳原子的烷基或3至5个碳原子的环烷基，其中至少有一个是氢之外的其他基团；R4是其羧酸；或当n等于或大于1时，R4可以是杂环芳基团，可能被取代或未取代，或胺（NR′R″）。R5是氢或酰基（如乙酰基或苯甲酰基）或其他能够生物转化以生成游离酚结构（其中R5-H）的基团。此外，提供了一种方法，用于预防、抑制或治疗与代谢功能障碍相关或依赖于T3调节基因表达的疾病，其中上述描述的化合物以治疗有效剂量给予。与代谢功能障碍相关或依赖于T3调节基因表达的疾病的例子包括肥胖症、高胆固醇血症、动脉粥样硬化、心律失常、抑郁症、骨质疏松症、甲状腺功能减退症、甲状腺肿、甲状腺癌以及青光眼、充血性心力衰竭和皮肤疾病。
• Bisaryl derivatives having FSH modulatory activity
  申请人：——

  公开号：US20040152703A1

  公开（公告）日：2004-08-05

  The invention relates to bisaryl derivatives of the formula I, 1 wherein (R,R) is selected from (H,H), O, (H,CH 3 ), (H,OH) and (H,CN); Ar is substituted phenyl and A is a group of formula II, III, IV or V: 2 An example is (3S,6S)-1-N-(7-phenylheptyl)-3-(4-(3,4,5-trimethoxyphenyl)benzyl)-4-N-methyl-6-methyl-2,5-dioxo-1,4-piperazine: 3 The compounds of the invention have FSH receptor modulatory activity and can be used for the control of fertility, for contraception or for treatment of hormone-dependent disorders.

  该发明涉及公式I的双芳基衍生物，其中(R,R)从(H,H)，O，(H,CH3)，(H,OH)和(H,CN)中选择；Ar是取代苯基，A是公式II，III，IV或V的基团之一：一个例子是(3S,6S)-1-N-(7-苯基庚基)-3-(4-(3,4,5-三甲氧基苯基)苯基)-4-N-甲基-6-甲基-2,5-二氧杂环己烷：该发明的化合物具有FSH受体调节活性，可用于控制生育、避孕或治疗激素依赖性疾病。
• Novel 1,4-benzothiazephine and 1,5-benzothiazepine compounds as inhibitors of apical sodium co-dependent bile acid transport and taurocholate uptake
  申请人：——

  公开号：US20020183307A1

  公开（公告）日：2002-12-05

  Compounds, pharmaceutical compositions, and methods for the treatment of a hyperlipidemic condition in a subject. The compounds of the present invention are apical sodium co-dependent bile acid transport inhibitors and are 1,4-benzothiazepine and 1,5-benzothiazepine compounds corresponding to Formula I: 1 wherein j, m, Y, Z, R 1A , R 1B , R 2A , R 2B and R 6 are as defined in the specification.

  本发明涉及用于治疗主题的高脂血症状况的化合物、药物组合物和方法。本发明的化合物是顶端钠依赖性胆汁酸转运抑制剂，是与式I：1相应的1,4-苯并噻吩和1,5-苯并噻吩化合物，其中j、m、Y、Z、R1A、R1B、R2A、R2B和R6如规范中所定义。